The Institute comprises 22 active research groups. Our Principal Investigators and their research areas are:
Professor Michael Ashford Disordered nutrient homeostasis: links to disease
Dr David Brighty Molecular biology of human retroviral infections
Professor Paul Clarke Cell cycle and apoptosis
Professor Helen Colhoun Public Health
Dr John Dillon Stress responses and biomarkers of liver disease
Dr Albena Dinkova-Kostova Reducing the risk of skin cancer by induction of cytoprotective responses
Professor John Hayes Molecular mechanisms of cancer chemoprevention and control of antioxidant pathways
Dr Colin Henderson Transgenic technology
Professor Kevin Hiom Signalling and repair of DNA damage
Professor Stephen Keyse Stress response
Professor Graham Leese Diabetes and epidemiology
Dr Rory McCrimmon CNS mechanisms that regulate glucose homeostasis in health and disease
Dr David Macfarlane Diabetes
Dr David Meek Regulation of the p53 tumour suppressor network
Professor Andrew Morris (Director), Diabetes
Professor Colin Palmer Lipid signalling in cancer and vascular disease
Dr Ewan Pearson Diabetes and population pharmacogenetic studies
Dr John Sharkey Molecular mechanisms underlying degenerative brain disorders
Dr Gillian Smith The molecular basis for individuality in disease susceptibility and treatment response
Dr Calum Sutherland Insulin signalling and disease
Professor Roland Wolf (Director), Identification and characterisation of genes that determine cellular and individual sensitivity to drugs and environmental agents
del.icio.us
digg
reddit
facebook
stumbleupon